Immune Checkpoint Inhibitor Nivolumab and Radiotherapy in Pretreated Lung Cancer Patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immune Checkpoint Inhibitor Nivolumab and Radiotherapy in Pretreated Lung Cancer Patients

Published:2018-11 Issue:11 Volume:41 Page:1101-1105
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Fiorica Francesco,Belluomini Lorenzo,Stefanelli Antonio,Santini Alessandra,Urbini Benedetta,Giorgi Carlotta,Frassoldati Antonio

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference24 articles.

1. High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation;Mu;Med Oncol,2011

2. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer;Borghaei;N Engl J Med,2015

3. The blockade of immune checkpoints in cancer immunotherapy;Pardoll;Nat Rev Cancer,2012

4. Safety and feasibility of radiotherapy treatment in elderly non-small-cell lung cancer (NSCLC) patients;Fiorica;Arch Gerontol Geriatr,2010

5. Antitumor efficacy of radiation plus immunotherapy depends upon dendritic cell activation of effector CDS+ T cells;Dovedi;Cancer Immunol Res,2016

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Palliative Thoracic Radiotherapy in the Era of Modern Cancer Care for NSCLC;Cancers;2024-08-29

2. Radiotherapy in the management of lung oligometastases;Cancer/Radiothérapie;2024-02

3. The Application of Immunotherapy in Non-Small Cell Lung Cancer;Advances in Clinical Medicine;2024

4. NUT carcinoma in pediatric patients: Characteristics, therapeutic regimens, and outcomes of 11 cases registered with the German Registry for Rare Pediatric Tumors (STEP);Pediatric Blood & Cancer;2023-12-26

5. Analysis of the risk factors of radiation pneumonitis and the predictive ability of dosiomics in non-small-cell lung cancer;Future Oncology;2023-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3